420 with CNW – First Specialist Medical Marijuana Clinic Opens in the UK

Last Saturday (March 9) saw history being made in the UK as the first specialist medical cannabis clinic opened in Manchester. The clinic is called The Beeches Consulting Center.

The opening of this clinic has been widely welcomed by patients and clinicians in the UK. This cannabis clinic is owned by European Cannabis Holdings (ECH), a group of companies that plans to open many more such clinics across the UK.

The clinic will be headed by two respected professionals in the medical field. These are an independent pain specialist, Dr. David McDowell, and the second is a consultant neurologist, Professor Mike Barnes.

Dr. McDowell also holds the distinction of being the first specialist to issue a medical cannabis prescription in the UK when the British government enacted a law that made it possible for patients to access medical cannabis starting from December 1. 2018.

Forzana Nazir is one of the first patients that Dr. McDowell issued a medical cannabis prescription to. She is eternally grateful for this because she has been able to transition from taking 13 different medications for her genetic disorder to just three prescription medications ever since she started taking medical marijuana.

Nazir suffers from Ehlers Danlos Syndrome that made her nearly bedridden on a permanent basis due to the severe pain, vomiting and nausea. She credits medical marijuana for significantly improving her quality of life and also for weaning her off many prescription opioids.

The opportunities offered by this new clinic have huge significance given the difficulties that patients have been experiencing if they want to access medical cannabis through the NHS (National Health Service).

Patients are required to establish exceptional clinical circumstances, exhaust all the current treatment options available in the UK, get approval from an NHS Trust Medical Director and then get a medical specialist who is willing to accept liability for their medical cannabis treatment. Only then can a patient receive medical marijuana from the NHS. Any wonder that only four patients have so far accessed the NHS medical marijuana?

The clinic in Manchester, and others that will be opened, will offer an alternative to the complicated bureaucracy associated with getting medical marijuana through the NHS. For now, the clinic will treat chronic pain (due to arthritis, spasticity, fibromyalgia, etc.), psychiatric conditions (anxiety, depression, PTSD, etc.) and neurological conditions, such as Parkinson’s disease, Alzheimer’s, multiple sclerosis and epilepsy.

Net Element, Inc. (NASDAQ: NETE) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) congratulate ECH upon that major milestone of opening the first specialized medical marijuana clinic in the UK. That is a major investment which should open the eyes of other businesses to the massive opportunities that exist in the cannabis industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – The US Cannabis Industry Has So Far Created 211,000 Full-Time Jobs

Because marijuana remains illegal at the federal level, it isn’t possible to get accurate statistics about the jobs available in the industry from federal agencies like the Bureau of Labor Statistics. However, Whitney Economics and Leafly.com decided to painstakingly gather the data from each state where cannabis is legal and their findings are eye-catching.

The data analysts discovered that so far, the legal cannabis industry has created 211,000 full-time jobs within the U.S. This shows that the industry is one to watch if the problem of unemployment is to be tackled.

The statistics collected show that out of the 211,000 full-time jobs created so far, 64,000 were filled in 2018 alone. Not bad for an industry that remains illegal at the federal level.

There is no indication that the increase in cannabis jobs is going to slow down any time soon. For example, 2017 saw a 21 percent increase in the number of jobs created in the industry while that number jumped to 44 percent in 2018. 2019 should show a higher rise in the percentage of new jobs created.

You may be wondering how the cannabis workforce increase compares to other sectors/industries. According to the Bureau of Labor Statistics, three industries are likely to have the highest increase in jobs over the coming ten years.

The demand for wind turbine technicians is expected to increase by 96 percent while the demand for solar voltaic installers is likely to increase by 105 percent. The need for home health care aides will rise by 47 percent. All these figures predict workforce increases over at least a decade. However, the data collected by Leafly and Whitney Economics shows that the marijuana industry will achieve a 110 percent increase in jobs created in just over three years!

The figures get even more astounding when they are broken down on a state-by-state basis. For example, Florida saw a 703 percent increase in the cannabis jobs created during 2018. New York ended 2018 with an extra 5,000 full-time jobs in the cannabis industry, marking an increase of 278 percent.

Five states (Oklahoma, California, Arkansas, Massachusetts and Florida) are currently in need of thousands of employees in the cannabis sector, and this demand may keep rising over the coming years as the industry matures. Net Element, Inc. (NASDAQ: NETE) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) welcome the research done by Leafly and its partners since this data proves that cannabis can bring huge economic benefits wherever it is legalized.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Does Legalization of Recreational Marijuana Mark the Death of Medical Cannabis Programs?

You may be wondering what becomes of the medical marijuana programs and products once a jurisdiction legalizes recreational pot. Some people even conclude that medical marijuana dies quietly once recreational cannabis becomes legal. Is this true?

It may be true that the process of getting a medical marijuana card is a bit cumbersome (find a doctor willing to recommend medical marijuana for your health challenge, then apply and pay license fees, etc.). The legalization of recreational cannabis means that access to marijuana now just requires you to present a valid government-issue photo ID at a dispensary or retail outlet in order to buy cannabis. Viewed from this angle, some patients may opt to buy recreational marijuana and use it to manage their symptoms.

However, one key reason why the legalization of recreational cannabis cannot mark the death of medical marijuana is that patients often require customized or specially formulated cannabis products to manage their symptoms or treat the qualifying conditions for which they were enrolled on the medical cannabis program. For this reason, the commencement of recreational sales cannot signal doom to medical cannabis.

Secondly, the legalization of recreational weed also boosts medical cannabis because it widens the market for marijuana products. That wider market generates a lot of interest among researchers and business entities. Consequently, more research will be conducted, and this research can result in a better understanding of how cannabis can be used to treat different conditions. This is clearly happening in Canada where recreational sales have sparked greater interest among cannabis researchers and innovators.

Thirdly, players in the cannabis industry may be unwilling to turn their backs upon their medical cannabis clients because these patients are more reliable clients when compared to recreational users. You see, a patient needs medical cannabis while cannabis is just a want to a recreational user. This means that addressing the needs of patients results in more assured business when compared to chasing the wind as you try to keep up with the fickle interests of recreational users. From a business perspective, medical cannabis ensures steady sales so it will stay despite the legalization of recreational sales.

More importantly, recreational cannabis normalizes medical cannabis. Patients are often viewed as disguised stoners in jurisdictions where only medical cannabis is legal. However, the end of cannabis prohibition often results in more information becoming available to people in that area. Consequently, they will develop a greater appreciation of the medical benefits of cannabis and patients will no longer have to be on the defensive as they use medical cannabis.

As you can see, the end of cannabis prohibition doesn’t necessarily mean that medical cannabis programs will suffer a slow death. MustGrow Biologics Corp. and Net Element, Inc. (NASDAQ: NETE) insist that different people have different needs, so it may not be right to think that the commencement of recreational sales means the death of medical cannabis.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Oregon Lawmaker Introduces Bill to Protect Cannabis Users Who Need Organ Transplants

A Portland lawmaker, Rep. Rob Nosse, has introduced House Bill 2687 geared at ensuring that medical cannabis users aren’t removed from the waiting list for organ transplants in the State.

This Bill will prevent medical practitioners from recommending that medical cannabis users be removed from the waiting list for organ transplants managed by different organizations in the State, such as United Network for Organ Sharing.

Approximately 850 people in Oregon are waiting to get a suitable match for an organ transplant, yet just 340 transplant surgeries were performed in the state last year.

Many of those people on the waiting list resort to medical marijuana in order to alleviate their severe symptoms.

In response to the bill introduced by Nosse, many of the transplant centers in Oregon denied that they turn away anyone who tests positive for marijuana.

Piseth Pich, one of Legacy Health’s community relations officials in Portland, revealed that their center assesses patients based on a number of requirements, including drugs tests, as a way to understand that patient’s overall health condition before that person is declared suitable for a transplant.

Pich added that it is hard to put a number on how many people who have been found unsuitable just by looking at only factor since suitability is determined on the basis of multiple factors.

It is common for someone to wait for years before ever finding a suitable organ, and even after the transplant process many people’s bodies reject the donated organ as foreign.

Representatives of the different transplant centers have expressed reservations about Nosse’s bill. For example, they say that the bill wants to make it legal for the transplant centers to disregard a factor that can have a bearing on the likely success of a transplant procedure.

While appearing before the House Committee on Health Care, Nosse presented a woman, Robin Socherman, whose situation can be regarded as a case study of what medical marijuana users go through when they need an organ transplant.

Robin Socherman is interested in donating a kidney to her husband, but he was removed from the waiting list after he tested positive for marijuana. Her husband, Jake Socherman, started using medical marijuana about six years ago to combat back pain. This pain has since been linked to his enlarged kidneys.

The transplant center advised Jake to stop using medical cannabis in order to be eligible for an organ transplant. However, he resumed using marijuana after his symptoms got worse, and the transplant center promptly removed him from the waiting list.

Nosse told the committee that cases like that of Socherman prompted him to introduce the bill so that medical cannabis users aren’t victimized when they need an organ. MustGrow Biologics Corp., Net Element (NASDAQ: NETE) and the entire marijuana industry agree that people like Jake Socherman need to be given all the legal protections that they can get so that their health doesn’t suffer just because they are consuming a legal product.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Craft Medical Cannabis Growers Form Co-op in British Columbia

Small medical cannabis growers and producers in the Canadian province of British Columbia are coming together to form a co-op in order to bridge the supply gap. This co-op venture will be incorporated at the provincial level instead of seeking national incorporation.

This undertaking involves a partnership with Victory Square Technologies and Grow Tech Labs. The supply shortages that have plagued the Canadian recreational cannabis market prompted the initiators of this co-op to take action.

The company will be called the British Columbia Small Cannabis Producer and Processor Co-op. This is intended to reflect the character of the province as a leader in the cannabis industry both nationally and internationally.

Barinder Rasode, the CEO of this new company, revealed during its launch that the entire province and the cannabis industry will benefit greatly if small producers and processors come together to continue making a contribution in the industry.

Rasode added that once these small players combine their capacity, they have the potential to become a formidable player in the cannabis industry not just in Canada but globally.

The new company is calling on small producers to send them an email expressing interest to join this new group and to get additional information about this new entity.

The co-founder and CEO of Victory Square Technologies (Shafin Diamond) remarked that he was excited to see that micro-growers of medical cannabis were coming forward to take part in the co-operative.

It is not clear whether the desire to combine forces wasn’t driven by a survival instinct. As the cannabis industry has grown, large scale operations have increasingly taken an upper hand due to their economies of scale that lower the cost of producing each unit of cannabis.

While production costs are being driven downwards, the cannabis market hasn’t sufficiently segmented (as yet) in order to sustain the niche growers and producers. Consequently, the small growers and producers may have felt some pressure on their profit margins as the large producers brought more products to the market at lower rates.

This pressure could be the reason why the initiators of the co-op decided that they should either combine forces or fold. Such a factor may explain why Grow Tech Labs and Victory Square Technologies were brought on board to provide a way to standardize the products from the small growers and producers.

If that is the case, then that is a positive step forward since the entire industry, including Net Element (NASDAQ: NETE) and Medical Cannabis Payment Solutions (OTC: REFG), would want every entity that can chip in to do so in order to nurture this nascent industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – What to Expect When Entering an Ohio Medical Marijuana Dispensary

The first medical marijuana dispensaries in Ohio opened on Wednesday, January 17 and many patients who were entering a dispensary for the first time didn’t know what to expect. Several operators of dispensaries shared their thoughts on how Ohio patients can make their visit to a dispensary seamless. This article discusses some of their suggestions.

Patients and Caregivers Only

The first thing that people who want to buy medical cannabis should know is that only patients and their caregivers will be allowed into a dispensary. Families are therefore advised to refrain from accompanying a patient to the dispensary since they will not be allowed to access the premises if they aren’t cardholders or caregivers.

Prepare In Advance

Patients and their caregivers are also advised to prepare adequately before heading out to a medical cannabis dispensary. This preparation includes confirming that one completed the registration process as well as setting aside cash for their purchase since dispensaries will not be accepting credit cards or health insurance. It is also prudent to carry the same photo ID that you used when enrolling for the program.

Don’t Touch

Medical cannabis dispensaries in Ohio will have a room in which patients and their caregivers can view the different products available. However, no one will be allowed to touch any product on display unless a dispensary employee permits them to. You can only see or smell the products.

No Onsite Consumption

Once a patient or their caregiver has selected what they will purchase, the products will be cleared at the check-out counter and you can leave the dispensary. No one is allowed to consume medical marijuana within the dispensary premises or anywhere in public. Ohio law stipulates that medical marijuana can only be consumed in the privacy of one’s home.

Check Dispensary Locations

So far, there are 56 medical marijuana dispensaries licensed by Ohio State. However, not all of them will be in position to open immediately, so patients are advised to check online and confirm that the dispensary they wish to buy products from will be open on the day one needs to visit the facility. For example, just 4 out of the 56 licensed dispensaries opened on Wednesday.

The medical marijuana dispensaries have indicated that they will give each patient as much time and information as possible in order to help them to select the best products for their needs. This promise is a welcome gesture because not many patients will be certain about what to buy for their conditions. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Net Element (NASDAQ: NETE) congratulate Ohio upon kick starting their medical cannabis program.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Three Medical Marijuana Issues That Iowa May Need to Revisit

Iowa legalized medical cannabis in 2014, but the rate at which the state has adapted to the changing realities of the industry is so slow that many have been left frustrated by how oblivious the state legislature is to the things that laypeople see every day. Of specific concern are the three issues below.

The Number of Licensed Dispensaries

The entire state of Iowa has only five medical cannabis dispensaries from which patients can legally acquire what they need for their health challenges. For example, Cedar Rapids doesn’t have any licensed dispensary within its borders and yet this is the second largest city in the state. How is it possible that no dispensary is located there and yet there is no local bylaw banning cannabis businesses from operating there?

This just goes to show that the authorities didn’t consider the demand for medical cannabis when passing the law that restricted the number of licensed dispensaries to just five. What they may not know is that such a limit can unwittingly encourage the black market to thrive in the state since the illicit supply can easily reach every corner of the state.

The Cap on THC Levels

The regulations in place limit how much THC medical cannabis can contain to 3 percent. THC is the cannabinoid that makes people “high”. The board overseeing the medical cannabis program voted unanimously to retain the 3 percent limit on THC for another year or two before revisiting the matter.

While it may be reasonable to set a limit on how much THC people consume when they buy medical cannabis, such a limit should not be so low that patients will be compelled to consume a larger quantity of cannabis in order to get the desired effects.

It would be better for the authorities to provide a rationale for that 3 percent THC limit and get feedback from experts and the public on the same before enacting it into law. As things stand, patients may be compelled to spend more money buying a larger quantity of cannabis since there is no cap on the quantity they can buy.

The Qualifying Conditions

Iowa is operating as though it is the first state to legalize medical cannabis and yet there are several precedents to learn from. California is reputed to have some of the strictest regulatory controls not just for medical cannabis but for everything else. However, California created a list of dozens of conditions for which medical cannabis could be bought long before recreational cannabis was legalized.

Iowa started by allowing medical cannabis for only epilepsy, then eased up a bit in 2017 to include a few more conditions. What is baffling is that post-traumatic stress disorder (PTSD), ADHD and bi-polar weren’t added to the list and yet nearly all other states include them among the qualifying conditions.

All in all, the board in charge of the medical marijuana program needs to be more foresighted and stop being reactive in its approach. Otherwise, the program will not attain its intended objectives. No one, including Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Net Element (NASDAQ: NETE), would want this beneficial program to fail.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Research Shows that Fewer Teens Consumed Cannabis in Washington after Legalization

Many opponents of cannabis legalization often argue that teens will use the substance once it is legalized. However, a recent study done in Washington State has found that such fears are unfounded.

The researchers carefully analyzed the data collected during the Washington Healthy Youth Surveys conducted in 2010-2012 and the data gathered during the 2014-2016 survey. The data clearly shows that the number of teens who reported that they use cannabis had declined.

Recreational marijuana was legalized in the state in 2012, so the researchers had a keen interest in comparing consumption rates before and after legalization.

The study found that marijuana use among eighth-graders dropped by nearly 3 percent from approximately 10 percent in the years just before legalization to approximately 7 percent in the data captured following legalization.

There was a drop of 2 percent among 10th graders since the rate stood at 20 percent in the data captured in the 2010-2012 surveys while the rate was 18 percent when those teens were surveyed in 2014-2016. There was no change in the percentage of 12th graders who consume cannabis.

However, the researchers were quick to point out that their findings do not in any way suggest that the drop in cannabis use among teens is entirely the result of legalization. They also added that their findings may not be an accurate indicator of what trend marijuana consumption among teens will take in the long-term.

The researchers suggested that more research needs to be done about the how the availability of cannabis in given neighborhoods affects the marijuana-use patterns of teens. Such research is necessary since what happens in the state capital may have little influence on what happens in particular neighborhoods.

The impact of advertising, packaging and the proximity of retail outlets should also be investigated to reveal how those factors influence the drug-use behavior of minors.

In the meantime, another study that was published shortly before the one on teenage cannabis use shows that the number of cannabis users in Washington State is almost twice what it was thought to be. This study makes the findings showing a lower prevalence of marijuana use among teens even more significant since it becomes clearer that legalization didn’t trigger a spike in the number of teens who can access and consume cannabis.

Cannabis industry participants like Net Element (NASDAQ: NETE) and Medical Cannabis Payment Solutions (OTC: REFG) are glad that verifiable scientific studies are disproving those who want to discredit cannabis at every opportunity.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – UN Committee Delays Release of Cannabis Scheduling Recommendations

The Expert Committee on Drug Dependence (ECDD) of the World Health Organization (WHO) met in November to discuss whether the scheduling of marijuana should be revised from its current status as a Schedule 1 substance to another less restrictive category. In a surprise move, the expected release of their findings has been postponed to January instead of this month as had earlier been indicated.

The ECDD called for, and received input from various stakeholders regarding various aspects of cannabis, such as its medicinal value as well as evidence of abuse or overdose incidents. The response to this call was massive, as was the situation when the FDA asked for input on the same matter in October.

The WHO committee subsequently released a pre-review report which had some positive findings about cannabis, such as the observation that no evidence had been presented that any fatality had ever occurred due to a cannabis overdose. The pre-review also indicated that there was evidence to show that some ingredients in cannabis can improve sleep and reduce pain.

The findings in the pre-review prompted the agency to take their examination a notch higher with a critical review done on the findings gathered. The findings of that in-depth critical review would then be used by the UN Commission on Narcotic Drugs to decide whether to revise the scheduling of cannabis or leave it in the category where it is currently listed.

It is the release of the recommendations made after the in-depth critical review that have been delayed until January next year.

The Expert Committee said more time was needed “for clearance reasons” before the recommendations are made public. This announcement poured cold water on the marijuana advocates’ spirits since they had expected a favorable recommendation on the basis of the findings stated in the pre-review.

Speculation is rife that the delay was motivated by political factors since a recommendation to reschedule cannabis would have imposed a lot of pressure on various authorities to adjust their stance on cannabis. Remember, the UN sets the agenda for many international policies and member states are expected to follow the suggestions made by the world body.

Whatever the true reason for the delay, the Commission on Narcotic Drugs will meet in March 2019 and vote on the scheduling of cannabis. So, a decision will still be made one way or the other, and it may be hard for the Commission to keep cannabis as a Schedule 1 substance yet pure CBD (cannabidiol) was removed from international scheduling so that access by patients isn’t restricted. CBD can be extracted from cannabis.

Industry players like Medical Cannabis Payment Solutions (OTC: REFG) and Net Element (NASDAQ: NETE) eagerly await the decision made by the UN since such a decision will have a global impact on how the cannabis industry evolves.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Why Cannabis Capsules are Gaining Popularity

This year saw three Canadian cannabis companies introduce marijuana capsules on the market following the lead taken by Tilray last year. This year also saw UC San Diego get permission from the DEA to import marijuana capsules for a clinical trial. So, what’s the deal with capsules? Why are they suddenly becoming popular?

The first reason why capsules are a hit in the market is because physicians and consumers find them convenient when one doesn’t want to make mistakes when measuring the quantity to consume, especially patients taking marijuana as a way to alleviating their medical conditions. The medical cannabis dispensary can simply advise the patient to take two capsules a day, or whatever number may be deemed necessary for a specific patient. Those instructions will be easier to follow, consistently, since the process of deciding how much cannabis to take is easy.

Secondly, it is easy to transport the cannabis capsules in case one needs a supply close by. For example, you can simply count out the number of capsules you will need for the days when you are going to be away from home. This is different from having to carry an entire bottle of cannabis oil, for example, thereby exposing it to the risk of total loss in case it spills or degrades due to the unfavorable conditions in which you are carrying the product.

Additionally, cannabis capsules are useful for those people who find themselves in environments where it isn’t possible for them to consume cannabis in the most common ways, such as by smoking or vaping it. Such a person can just pop a capsule (or two or three) and get on with whatever he or she was doing, and none nearby will be the wiser.

Let’s face it, marijuana is still a divisive substance, regardless of what the law says in various jurisdictions. Consequently, consumers often face varying levels of stigmatization as they exercise the freedom granted by law to consume cannabis either for medical or recreational reasons. Once again, capsules can come to the rescue of the individuals who want to be discreet regarding their use of marijuana.

However, it isn’t all rosy for cannabis capsules just yet.

One shortcoming of cannabis capsules is that they cannot be standardized as yet since every individual requires a different quantity of marijuana in order to get the desired effects, whether it is feeling high or getting relief from the symptoms of a medical condition. It may therefore be expensive to ask for the contents of capsules to be customized for your needs, or you will have to make do with the estimated contents from mass-produced capsules.

The other question is: do you prepare the capsules yourself, or buy them from a manufacturer/retailer like MedReleaf Corp.? The source of the capsules is important because it will determine whether you are getting a consistent quality and quantity of cannabis that can trigger the desired effects. For now, buying from a licensed producer or dispensary seems a better route than going the DIY way.

As you can see from the discussion above, marijuana capsules look set to rise to higher levels over the years because of the many advantages that they bring. Industry insiders like Medical Cannabis Payment Solutions (OTC: REFG) and Net Element (NASDAQ: NETE) welcome every innovation, such as capsules, which makes it easier for people to access the cannabis they need for different purposes.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com